Table 2.
Univariate | Multivariate† | |||
---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
Group | ||||
Non-melanoma | Reference | Reference | ||
Melanoma | 1.58 (1.27–1.97) | <0.0001 | 1.46 (1.17–1.82) | <0.001 |
Age | ||||
≤54 | Reference | Reference | ||
55–69 | 2.67 (1.49–4.77) | 0.001 | 2.21 (1.23–3.96) | 0.008 |
≥70 | 18.64 (10.96–31.72) | <0.0001 | 11.76 (6.84–20.24) | <0.0001 |
Sex | ||||
Female | Reference | Reference | ||
Male | 1.15 (0.99–1.33) | 0.078 | 1.10 (0.94–1.28) | 0.246 |
Monthly income (NT$) | ||||
<20,000 | Reference | Reference | ||
20,001–40,000 | 0.90 (0.77–1.05) | 0.186 | 1.09 (0.86–1.39) | 0.473 |
>40,000 | 0.58 (0.46–0.74) | <0.0001 | 1.11 (0.88–1.42) | 0.380 |
Residential region | ||||
Northern | Reference | Reference | ||
Central | 1.26 (1.04–1.51) | 0.016 | 1.07 (0.88–1.30) | 0.503 |
Southern | 1.19 (0.99–1.43) | 0.061 | 1.07 (0.89–1.29) | 0.487 |
Others | 0.90 (0.67–1.20) | 0.471 | 0.81 (0.60–1.09) | 0.158 |
Hypertension | 2.22 (1.91–2.58) | <0.0001 | 1.09 (0.93–1.28) | 0.304 |
Hyperlipidemia | 0.66 (0.54–0.82) | <0.001 | 0.43 (0.35–0.54) | <0.0001 |
Charlson comorbidity index score | ||||
0 | Reference | Reference | ||
1 | 2.65 (2.15–3.26) | <0.0001 | 1.99 (1.61–2.47) | <0.0001 |
2 | 4.88 (3.92–6.09) | <0.0001 | 3.13 (2.49–3.93) | <0.0001 |
3 | 5.48 (4.26–7.04) | <0.0001 | 3.36 (2.59–4.35) | <0.0001 |
≥4 | 7.77 (6.19–9.75) | <0.0001 | 4.77 (3.75–6.06) | <0.0001 |
†Adjusted for age, sex, hypertension, hyperlipidemia, monthly income, residential region, and Charlson comorbidity index score.